These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8670270)

  • 1. The catalytic properties of human hepatitis B virus polymerase.
    Jeong JH; Kwak DS; Rho HM; Jung G
    Biochem Biophys Res Commun; 1996 Jun; 223(2):264-71. PubMed ID: 8670270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection.
    Ono-Nita SK; Kato N; Shiratori Y; Masaki T; Lan KH; Carrilho FJ; Omata M
    Hepatology; 1999 Mar; 29(3):939-45. PubMed ID: 10051501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNase H activity of human hepatitis B virus polymerase expressed in Escherichia coli.
    Lee YI; Hong YB; Kim Y; Rho HM; Jung G
    Biochem Biophys Res Commun; 1997 Apr; 233(2):401-7. PubMed ID: 9144547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ø29 DNA polymerase residue Lys383, invariant at motif B of DNA-dependent polymerases, is involved in dNTP binding.
    Saturno J; Lázaro JM; Esteban FJ; Blanco L; Salas M
    J Mol Biol; 1997 Jun; 269(3):313-25. PubMed ID: 9199402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of an enzymatically active polymerase of human hepatitis B virus in an coupled transcription-translation system.
    Li Z; Tyrrell DL
    Biochem Cell Biol; 1999; 77(2):119-26. PubMed ID: 10438146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of polymerase activity due to Tyr to Phe substitution in the YMDD motif of human immunodeficiency virus type-1 reverse transcriptase is compensated by Met to Val substitution within the same motif.
    Harris D; Yadav PN; Pandey VN
    Biochemistry; 1998 Jul; 37(27):9630-40. PubMed ID: 9657675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse transcriptase activity of hepatitis B virus (HBV) DNA polymerase within core capsid: interaction with deoxynucleoside triphosphates and anti-HBV L-deoxynucleoside analog triphosphates.
    Lam W; Li Y; Liou JY; Dutschman GE; Cheng YC
    Mol Pharmacol; 2004 Feb; 65(2):400-6. PubMed ID: 14742682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.
    Tipples GA; Ma MM; Fischer KP; Bain VG; Kneteman NM; Tyrrell DL
    Hepatology; 1996 Sep; 24(3):714-7. PubMed ID: 8781348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of protein phosphatase 1 catalytic subunit to a Mn(2+)-dependent enzyme impairs its regulation by inhibitor 1.
    Endo S; Connor JH; Forney B; Zhang L; Ingebritsen TS; Lee EY; Shenolikar S
    Biochemistry; 1997 Jun; 36(23):6986-92. PubMed ID: 9188695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in japanese patients with chronic hepatitis B.
    Ogata N; Fujii K; Takigawa S; Nomoto M; Ichida T; Asakura H
    J Med Virol; 1999 Nov; 59(3):270-6. PubMed ID: 10502255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of an active form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion protein containing the C-terminal region of the Ty1 integrase linked to the reverse transcriptase-RNase H domain exhibits polymerase and RNase H activities.
    Wilhelm M; Boutabout M; Wilhelm FX
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):337-42. PubMed ID: 10816427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional roles of carboxylate residues comprising the DNA polymerase active site triad of Ty3 reverse transcriptase.
    Bibillo A; Lener D; Klarmann GJ; Le Grice SF
    Nucleic Acids Res; 2005; 33(1):171-81. PubMed ID: 15647500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A putative new domain target for anti-hepatitis B virus: residues flanking hepatitis B virus reverse transcriptase residue 306 (rtP306).
    Wang YX; Xu X; Luo C; Ma ZM; Jiang HL; Ding JP; Wen YM
    J Med Virol; 2007 Jun; 79(6):676-82. PubMed ID: 17457904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
    J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant Thermus thermophilus His6-DNA polymerase with reverse transcriptase activity].
    Smirnov IuV; Chakhmakhcehva OG; Efimov VA
    Bioorg Khim; 1997 Apr; 23(4):257-61. PubMed ID: 9221727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems with particle-associated DNA polymerase assays in the diagnosis of plasma-suspended viruses.
    Lorenz PR
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):25-38. PubMed ID: 92114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
    Harris JM; McIntosh EM; Muscat GE
    J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
    Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
    Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.